Valproate original pack dispensing — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Supply in original packaging with patient information and visual pregnancy warnings where possible
Valproate has strict risk minimisation requirements because of teratogenicity and neurodevelopmental harm. Original packs with warnings and patient information should be used where possible, and counselling should reinforce Pregnancy Prevention Programme requirements. Plain repackaging can remove critical safety information. Prior use does not remove the need for ongoing safety communication.
Reference: BNF; MHRA Drug Safety Update; MEP